CRISPR-based treatment

New Gene Therapy: Single Dose Slashes ‘Bad’ Cholesterol by 50%

A groundbreaking gene therapy, VERVE-101, developed by Verve Therapeutics, holds promise in reducing ‘bad’ cholesterol levels by up to 50%…

Read More »